Qube Research & Technologies LTD Celldex Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 125,506 shares of CLDX stock, worth $5.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

125,506

Previous 206,164 39.12%

Holding current value

$5.17 Million

Previous $8.65 Million 46.32%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $2.64 Million - $3.43 Million	-80,658 Reduced 39.12%	125,506 $4.64 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $5.68 Million - $8.36 Million	161,196 Added 358.47%	206,164 $8.65 Million
Q4 2023 Feb 13, 2024	BUY	$22.61 - $40.65 $919,526 - $1.65 Million	40,669 Added 946.01%	44,968 $1.78 Million
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $1.64 Million - $2.42 Million	-64,548 Reduced 93.76%	4,299 $118,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $209,061 - $264,208	6,902 Added 11.14%	68,847 $2.34 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $983,265 - $1.34 Million	28,271 Added 83.95%	61,945 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $727,780 - $1.19 Million	26,198 Added 350.43%	33,674 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $169,705 - $280,873	7,476 New	7,476 $210,000
Q2 2021 Aug 13, 2021	SELL	$20.71 - $35.37 $1.34 Million - $2.3 Million	-64,913 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$16.19 - $29.91 $1.72 Million - $3.18 Million	-106,405 Reduced 62.11%	64,913 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.47 Million - $2.22 Million	97,734 Added 132.82%	171,318 $3 Million
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $359,462 - $565,827	37,250 Added 102.52%	73,584 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $58,497 - $487,238	36,334 New	36,334 $472,000

Others Institutions Holding CLDX

# of Institutions

195

Shares Held

63.4M

Call Options Held

206K

Put Options Held

176K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.93B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Celldex Therapeutics, Inc. Transaction History